5 Things to Know About the New Drug Pricing Negotiations
The Biden administration unveiled the first 10 drugs subject to price negotiations, taking a swipe at the pharmaceutical industry. But what does it mean for patients?
After Backlash, Feds Cancel Plan That Risked Limiting Breast Reconstruction Options
The Centers for Medicare & Medicaid Services backed off from a plan that could have curtailed access to a type of reconstructive surgery known as DIEP flap. Breast cancer patient advocates are relieved.
The Painful Pandemic Lessons Mandy Cohen Carries to the CDC
Mandy Cohen, the new director of the Centers for Disease Control and Prevention, earned praise for her leadership and communication as the face of North Carolina’s response to covid-19. People in the state’s most vulnerable communities tell a more complicated story.
Seeking Medicare Coverage for Weight Loss Drugs, Pharma Giant Courts Black Influencers
Novo Nordisk, the dominant company in the multibillion-dollar market for weight loss drugs, focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease that needs treatment.
How a Medical Recoding May Limit Cancer Patients’ Options for Breast Reconstruction
The federal government’s arcane process for medical coding is influencing which reconstructive surgery options are available, creating anxiety for breast cancer patients.
A Catch-22 for Clinics: State Bans Limit Abortion Counseling. Federal Title X Rules Require It.
Family planning clinics are getting caught between state abortion bans and a federal requirement to refer patients for abortion care on request.
End of Covid Emergency Will Usher in Changes Across the US Health System
The May 11 expiration of the federal government’s pandemic emergency declaration will affect patient care across a broad range of settings, including telemedicine, hospitals, and nursing homes.
Why Medicaid Expansion Ballots May Hit a Dead End After a Fleeting Victory in South Dakota
Since 2017, Medicaid expansion has been adopted in seven states where a question was placed directly on the ballot. But campaign leaders say that strategy may not work in Florida and Wyoming, where Republican opposition remains strong.
The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice.
Private equity-backed Headlands Research heralded its covid-19 vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.
Para lanzar un nuevo fármaco al mercado, la Administración de Alimentos y Medicamentos (FDA) exige a las farmacéuticas estudios exhaustivos para demostrar su seguridad y eficacia. Conseguir que un medicamento salga al mercado unos meses antes, y con menos gastos de lo habitual, puede traducirse en beneficios millonarios para el fabricante.